High materiality7/10
Atrium Therapeutics initiated with an Overweight at Cantor Fitzgerald
Why it may matterVerify against the original reporting
overweight initiation
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald initiates Overweight on RNA (Atrium Therapeutics); target $25; posted price $12.48.
- Cantor Fitzgerald initiates Overweight on RNA; target $25.
Key facts
- 01
Target: $25
- 02
Posted price: $12.48
- 03
Analyst firm: Cantor Fitzgerald
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.